EMZF-1--A NOVEL GENE REQUIRED FOR EMBRYONIC HEMATOPOIESIS

EMZF-1--胚胎造血所需的新基因

基本信息

  • 批准号:
    6101895
  • 负责人:
  • 金额:
    $ 29.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-06-01 至 2001-05-31
  • 项目状态:
    已结题

项目摘要

The hematopoietic system in mammals is composed of diverse cell types that perform distinct and specialized functions. These terminally differentiated cells are short-lived, formed from a pool of totipotent hematopoietic stem cells (HSC) whose presumptive origin is the mesodermal cells of the yolk sac blood islands. Although progress has been made in the identification of HSC activity from the adult bone marrow, no such homogeneous cell population has been identified, and no genetic markers exist to identify such cells. We hypothesize that transcripts unique to the earliest HSC will provide genetic lineage markers enabling us to trace and manipulate the development of the primordial HSC. Using a molecular genetic approach we have recently identified a novel cDNA clone from a 9.5 day blood island/yolk sac cDNA library using the human myeloid zinc finger (MZF)-1 cDNAproble. This newly identified cDNA clone, extraembryonic mesoderm zinc finger-1 (EM ZF-1), was shown to be expressed exclusively in the extraembryonic mesoderm of the yolk sac, ina the fetal liver and heart of developing embryos and in the bone marrow, spleen and thymus of adult mice suggesting a role in mammalian hematopoiesis. This gene is located on mouse chromosome 5 and contains 12 C2H2 Kruppel-like zinc finger motifs in two separate regions which are highly homologous to several of the finger domains in MZF-1. EMZF-1 also contains an alanine/arginine-rich region downstream from the zinc finger motif. Such a domain has been found in other zinc finger genes and appears to be important for transcriptional regulation. The EMZF-1 gene maps to human chromosome 7 in an area associated with myeloid and lymphoid leukemias. Interestingly, PLZF, a newly discovered gene identified as a fusion partner with retinoid acid receptor-alpha in a variant t (11;17) translocation associated with acute promyelocytic leukemia, is also homologous to EMZF-1. Thus, EMZF-1 is the third member of a newly formed hematopoietic-specific zinc finger gene family whose function appears to be in the control of hematopoietic differentiation. The functional requirement for the EMZF-1 gene product appears early in mouse development since antisense oligonucleotides specific for EMZF-1 abrogates hematopoiesis in 14.5 day fetal liver and adult bone marrow cultures in vitro. Finally, another cDNA clone demonstrating high cross reactivity to the EMZF-1 was identified. This clone, LM-1D has been partially sequenced and determined to be an independent cDNA. We propose to characterize the lineage-specific expression of EMZF-1, identify its genomic structure and promoter elements and to begin the analysis of its function in vivo. The potential of EMZF-1 and the highly related LM-1D clone as molecular markers of primordial HSCs will be explored in vitro and in vivo and their function in hematopoiesis and leukemigenesis elucidated.
哺乳动物的造血系统由不同的细胞类型组成, 执行不同的和专门的功能。这些最终 分化的细胞是短命的,从全能的细胞池形成。 假定起源于中胚层的造血干细胞(HSC) 卵黄囊血岛的细胞。虽然在这方面取得了进展, 从成人骨髓中鉴定HSC活性, 已鉴定出同质细胞群,且无遗传标记 来识别这些细胞。我们假设, 最早期的HSC将提供遗传谱系标记, 并控制原始HSC的发育 利用分子遗传学方法,我们最近发现了一个新的cDNA 使用人的9.5天血岛/卵黄囊cDNA文库克隆 髓样锌指(MZF)-1 cDNA探针。这个新鉴定的cDNA克隆, 胚外中胚层锌指蛋白-1(EM ZF-1)表达于 只存在于卵黄囊的胚外中胚层中,在胎儿中, 发育中胚胎的肝脏和心脏以及骨髓、脾脏和 成年小鼠的胸腺,表明在哺乳动物造血中的作用。这 基因位于小鼠5号染色体上,含有12个C2 H2 Kruppel样 锌指基序在两个独立的区域,这是高度同源的 MZF-1中的几个指状结构域。EMZF-1还包含一个 在锌指基序下游的富含丙氨酸/丙氨酸的区域。等 在其他锌指基因中发现了一个结构域, 对转录调控很重要。EMZF-1基因定位于人类 7号染色体与髓细胞和淋巴细胞白血病相关。 有趣的是,PLZF,一个新发现的基因被鉴定为融合伴侣, 在变异t(11;17)易位中伴有维甲酸受体-α 与急性早幼粒细胞白血病相关,也与EMZF-1同源。 因此,EMZF-1是一个新形成的造血特异性转录因子的第三个成员。 锌指基因家族,其功能似乎是在控制 造血分化EMZF-1的功能要求 基因产物在小鼠发育早期出现, EMZF-1特异性寡核苷酸在14.5天内消除造血 胎肝和成人骨髓体外培养。最后,另一个cDNA 鉴定了对EMZF-1表现出高交叉反应性的克隆。 这个克隆LM-1D已经部分测序,并确定是一个克隆。 独立cDNA。我们建议将谱系特异性 EMZF-1的表达,鉴定其基因组结构和启动子元件 并开始分析其体内功能。EMZF-1的潜力 LM-1D克隆作为原始HSC的分子标记 将在体外和体内进行研究,并探讨其在造血中的作用 并阐明了白血病的发生。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAY L ROTHSTEIN其他文献

JAY L ROTHSTEIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAY L ROTHSTEIN', 18)}}的其他基金

Immune cell targeting of corticosteroids transforms the treatment of severe, chronic inflammatory diseases
皮质类固醇的免疫细胞靶向改变了严重慢性炎症性疾病的治疗
  • 批准号:
    10435587
  • 财政年份:
    2021
  • 资助金额:
    $ 29.02万
  • 项目类别:
Immune cell targeting of corticosteroids transforms the treatment of severe, chronic inflammatory diseases
皮质类固醇的免疫细胞靶向改变了严重慢性炎症性疾病的治疗
  • 批准号:
    10324755
  • 财政年份:
    2021
  • 资助金额:
    $ 29.02万
  • 项目类别:
Immune cell targeting of corticosteroids transforms the treatment of severe, chronic inflammatory diseases
皮质类固醇的免疫细胞靶向改变了严重慢性炎症性疾病的治疗
  • 批准号:
    10625527
  • 财政年份:
    2021
  • 资助金额:
    $ 29.02万
  • 项目类别:
Targeting leukocyte metabolism to treat human autoimmune disease
靶向白细胞代谢治疗人类自身免疫性疾病
  • 批准号:
    9763441
  • 财政年份:
    2018
  • 资助金额:
    $ 29.02万
  • 项目类别:
Targeting the checkpoint regulator VISTA for treatment of inflammatory disease
靶向检查点调节因子 VISTA 治疗炎症性疾病
  • 批准号:
    9255938
  • 财政年份:
    2017
  • 资助金额:
    $ 29.02万
  • 项目类别:
Targeting the checkpoint regulator VISTA for treatment of inflammatory disease
靶向检查点调节因子 VISTA 治疗炎症性疾病
  • 批准号:
    9752441
  • 财政年份:
    2017
  • 资助金额:
    $ 29.02万
  • 项目类别:
Safe and effective anti CD154 antibodies for therapeutic intervention
用于治疗干预的安全有效的抗 CD154 抗体
  • 批准号:
    9202640
  • 财政年份:
    2012
  • 资助金额:
    $ 29.02万
  • 项目类别:
Safe and effective anti CD154 antibodies for therapeutic intervention
用于治疗干预的安全有效的抗 CD154 抗体
  • 批准号:
    9271146
  • 财政年份:
    2012
  • 资助金额:
    $ 29.02万
  • 项目类别:
Role of Tcl-1 in Lymphoid Development
Tcl-1 在淋巴发育中的作用
  • 批准号:
    6340778
  • 财政年份:
    2000
  • 资助金额:
    $ 29.02万
  • 项目类别:
Role of Tcl-1 in Lymphoid Development
Tcl-1 在淋巴发育中的作用
  • 批准号:
    6232701
  • 财政年份:
    1999
  • 资助金额:
    $ 29.02万
  • 项目类别:

相似海外基金

Development of a method for preserving transplanted lung function using Gapmer-type antisense nucleic acid
开发利用Gapmer型反义核酸保存移植肺功能的方法
  • 批准号:
    22K09003
  • 财政年份:
    2022
  • 资助金额:
    $ 29.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Myostatin antisense nucleic acid therapy for rhabdomyosarcoma
肌肉生长抑制素反义核酸治疗横纹肌肉瘤
  • 批准号:
    21K07762
  • 财政年份:
    2021
  • 资助金额:
    $ 29.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Suppression of PHOX2B (+7Ala mutant) expression by antisense nucleic acid
反义核酸抑制 PHOX2B(7Ala 突变体)表达
  • 批准号:
    20K16927
  • 财政年份:
    2020
  • 资助金额:
    $ 29.02万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Pathogenesis and Antisense nucleic acid, glycosylation supplementation, and AAV therapy development forFukuyama muscular dystrophy and related diseases
福山性肌营养不良症及相关疾病的发病机制和反义核酸、糖基化补充以及 AAV 疗法的开发
  • 批准号:
    20H00526
  • 财政年份:
    2020
  • 资助金额:
    $ 29.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Synthesis of antisense nucleic acid incorporating cyclic sulfonamide backbone
掺入环状磺酰胺主链的反义核酸的合成
  • 批准号:
    20K21245
  • 财政年份:
    2020
  • 资助金额:
    $ 29.02万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Antisense nucleic acid splice correction therapy for Duchenne muscular dystrophy and related disorders
杜氏肌营养不良症及相关疾病的反义核酸剪接校正疗法
  • 批准号:
    G0900887/1
  • 财政年份:
    2011
  • 资助金额:
    $ 29.02万
  • 项目类别:
    Research Grant
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID "2'-PHOSPHORYLATED RNAS" -DIRECTED TOWARD ITS BASIC STRUCTURAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
反义核酸新材料“2-磷酸化RNAS”的化学合成-针对其基础结构研究和HIV病毒表达调控-
  • 批准号:
    05558090
  • 财政年份:
    1993
  • 资助金额:
    $ 29.02万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID"2"PHOSTHORYLATEDRNAS" DIRETED TOWARD IIS BASIC STRUCTRAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
针对 IIS 基础结构研究和 HIV 病毒表达调控的反义核酸新材料“2”磷酸化 RNA 的化学合成-
  • 批准号:
    04453031
  • 财政年份:
    1992
  • 资助金额:
    $ 29.02万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了